Physician profile
Mark Silberman
NPI 1780769653
$1,110.57
in general payments reported to CMS, 2019-2025
17 companies · $73.75 in 2025
The $73.75 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $98.68 · 2021: $98.30 · 2022: $221 · 2023: $138 · 2024: $286 · 2025: $73.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $319.13 | 2019-2022 | |
| Abbvie INC. | $189.29 | 2023-2024 | Alloderm, Botox |
| Cumberland Pharmaceuticals, INC. | $133.87 | 2019-2024 | Caldolor |
| Apyx Medical Corporation | $73.53 | 2019-2020 | |
| Sientra, INC. | $64.87 | 2022 | |
| Innovation Technologies INC | $46.81 | 2024 | Irrisept |
| Tela Bio, INC. | $45.56 | 2024 | Ovitex 2s |
| Stryker Corporation | $42.39 | 2025 | Spy-Phi System |
| Musculoskeletal Transplant Foundation INC. | $39.54 | 2024-2025 | |
| Integra Lifesciences Corporation | $27.34 | 2020 | |
| Acumed LLC | $23.49 | 2023 | Acumed, Inframe Implant, Osteomed |
| Axogen | $22.46 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Trevena, INC. | $19.64 | 2021 | |
| Ethicon US, LLC | $18.00 | 2024 | Dermabond, Stratafix |
| Mimedx Group, INC. | $16.57 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $14.15 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Silberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.